Cardiovascular and aerobic outcomes following growth hormone treatment in short-statured children

Overview

This study evaluated the effects of recombinant human growth hormone (r-hGH) on aerobic capacity and cardiac function in prepubertal children with short stature. While r-hGH therapy improved cardiac remodeling, no overall enhancement in aerobic capacity was observed over one year.

Background

Recombinant human growth hormone (r-hGH) is used to promote growth in children with growth hormone deficiency (GHD) and other short stature conditions. Understanding its impact on aerobic capacity and cardiac function is crucial, as these factors can influence long-term health outcomes. This study aims to clarify the relationship between r-hGH therapy and these parameters in a pediatric population.

Data Highlights

Key Findings

• r-hGH significantly increased IGF-1 and left ventricular mass indices.
• VO2max showed no overall improvement; a significant decrease was observed in GHD children, particularly girls.
• Only GHD males exhibited supranormal VO2max values at baseline, which persisted at 12 months.
• GLSR improved significantly at 6 months in GHD patients, indicating early myocardial response to GH therapy.
• No correlation was found between VO2max evolution and cardiac parameters.

Clinical Implications

The findings suggest that while r-hGH therapy may lead to favorable cardiac remodeling, it does not necessarily enhance aerobic capacity in short-statured children. Clinicians should monitor both cardiac function and aerobic performance during r-hGH therapy.

Conclusion

Revise to strictly summarize the study's findings without additional implications.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Pediatric Endocrine Society, GH Deficiency, Idiopathic Short Stature, and IGF-I Deficiency Treatment Guidelines (HRP 2016)
3. The Journal of Clinical Endocrinology & Metabolism — Impact of Growth Hormone Deficiency and Replacement Therapy on Physical Fitness Related to Health in Pediatric Patients
4. Frontiers in Endocrinology — Growth hormone therapy after hematopoietic cell transplantation in childhood: a nationwide survey and longitudinal cohort study
5. The Journal of Clinical Endocrinology & Metabolism — Bioactive IGF-I Levels in Pediatric Patients Undergoing Growth Hormone Treatment
6. The Journal of Clinical Endocrinology & Metabolism — Shifts in Documented Results of Growth Hormone Treatment in Pediatric Patients with Growth Hormone Deficiency
7. Normal Values for Speckle-Tracking Echocardiography in Children
8. Impact of Growth Hormone Deficiency and Replacement Therapy on Physical Fitness Related to Health in Pediatric Patients
9. GH Deficiency, Idiopathic Short Stature, and IGF-I Deficiency Treatment Guidelines (HRP 2016) - Pediatric Endocrine Society
10. Frontiers | CARDIAC AND AEROBIC RESPONSE TO GROWTH HORMONE THERAPY IN CHILDREN WITH SHORT STATURE: A PROSPECTIVE STUDY USING VO₂MAX AND SPECKLE TRACKING ECHOCARDIOGRAPHY